Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3361  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  ╗ Next article
  ╗ Previous article 
  ╗ Table of Contents
  
 Resource Links
  ╗  Similar in PUBMED
 ╗  Search Pubmed for
 ╗  Search in Google Scholar for
 ╗Related articles
  ╗  Article in PDF (112 KB)
  ╗  Citation Manager
  ╗  Access Statistics
  ╗  Reader Comments
  ╗  Email Alert *
  ╗  Add to My List *
* Registration required (free)  

 
  In this Article
   Abstract
   Materials and Me...
   Results
   Discussion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed8128    
    Printed190    
    Emailed4    
    PDF Downloaded276    
    Comments [Add]    
    Cited by others 9    

Recommend this journal

 


 
ORIGINAL ARTICLE
Year : 2005  |  Volume : 53  |  Issue : 2  |  Page : 197-201

Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis


Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012, India

Date of Acceptance03-Mar-2005

Correspondence Address:
Preeti Sahota
Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.16409

Rights and Permissions

 ╗ Abstract 

Background: In patients with multiple sclerosis (MS), transcranial magnetic stimulation (TMS) has shown significant prolongation of central motor conduction time (CMCT). Abnormal CMCT may reflect sub-clinical involvement of motor pathways and correlate with clinical motor disability. Objective: To determine the diagnostic yield of TMS in MS and the possible correlation of TMS abnormalities with clinical disability. Materials and Methods: Thirty patients with clinically definite MS presenting in acute relapse or with progressive disease course and 30 healthy controls were evaluated. TMS parameters evaluated included threshold intensity, motor evoked potentials (MEP) amplitudes and latencies and CMCT. Reassessment studies were done after three months. Statistical analysis: Student t-test, Mann-Whitney U test and Spearman's rank correlation test were used to assess the relationships. Results: Patients with MS had significantly higher threshold intensities, prolonged CMCT and reduced MEP amplitudes as compared to controls. Abnormalities in at least one parameter were observed in 86.7% of patients. When inter-side asymmetries in MEP latency and/or in CMCT were considered, the diagnostic yield increased to 96.7%. The diagnostic yield was 74.7% for visual evoked potentials, 13.3% for brainstem auditory evoked response and 10% for cerebrospinal fluid oligoclonal band. One MS patient without pyramidal or cerebellar dysfunction had prolonged CMCT. CMCT abnormalities correlated significantly with the degree of pyramidal signs, limb ataxia, intention tremor, dysdiadokokinesia and overall cerebellar score. In patients who had clinical improvement, follow-up studies showed improvement in CMCT parameters. Conclusion: TMS is a highly sensitive technique to evaluate cortico-spinal conduction abnormalities in MS that may have no clinical correlate and in monitoring the course of the disease. The effects of cerebellar dysfunction on TMS results need further evaluation.


Keywords: Magnetic stimulation, central motor conduction, motor evoked potential, pyramidal dysfunction


How to cite this article:
Sahota P, Prabhakar S, Lal V, Khurana D, Das CP, Singh P. Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis. Neurol India 2005;53:197-201

How to cite this URL:
Sahota P, Prabhakar S, Lal V, Khurana D, Das CP, Singh P. Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis. Neurol India [serial online] 2005 [cited 2019 Sep 22];53:197-201. Available from: http://www.neurologyindia.com/text.asp?2005/53/2/197/16409


Over the past few years, interest in evoked potentials (EP) in patients with multiple sclerosis (MS) has shifted from diagnostic applications to their validity as objective parameters of the disease course.[1],[2],[3] Among the EPs, transcranial magnetic stimulation (TMS) has been shown to be the single most sensitive diagnostic test among the evoked potentials in patients with MS.[4],[5],[6],[7] In these patients, TMS has revealed significant prolongation of central motor conduction time (CMCT).[8],[9],[10] It may also detect sub-clinical lesions and CMCT abnormalities may be related to clinical motor disability.[11],[12],[13] The possible role of cerebellar dysfunction with regards to TMS abnormalities in MS is not clear although increased threshold intensities and/or abnormal CMCT have been reported in late onset cerebellar atrophies and cerebellar stroke.[14],[15]

The present study was undertaken to determine the diagnostic yield of TMS in clinically definite MS besides other methods, to assess the strength of the correlation between clinical disability and TMS abnormalities and to evaluate the possibility that TMS may be used to monitor clinical response in MS over time.


 ╗ Materials and Methods Top


The present study was done on 30 consecutive patients of clinically definite MS,[16] admitted between January 2002 and June 2003. Patients included both patients in acute relapse and patients with progressive course. Patients with the history of epilepsy, neurosurgery or pacemaker implants were excluded. A relapse was defined as an increase in the neurological symptoms at least lasting for more than 24 hours, starting within at least two months prior to the evaluation. Ethical clearance was obtained from the local review board and written, informed consent was taken from all the subjects.

All the subjects underwent detailed history taking, systemic and neurological examination. The patients were clinically examined using the following scales:

1) Kurtzke's Expanded Disability status scale (EDSS) and complementary system of grades within 8 "functional systems".[17]

2) Pyramidal tract function was assessed by muscle strength and reflex grading. Muscle strength was assessed and scored according to the Medical Research Council scale. Deep tendon reflexes (DTR) were classified as normal (0), increased but not necessarily to a pathological degree (1), and markedly hyperactive, often with associated clonus (2); Hoffmann sign was scored as incomplete (1) if only thumb or index finger responded, and complete (2) when definitely positive; Babinski sign was scored as incomplete (1), characteristic (2), or with pathologic shortening reflex present (3).[13]

3) Cerebellar symptoms were rated on a scale ranging from 0 (absent) to 35 (most severe).[18] All the scores were analyzed as percentage of the most severe scale range and an adequate knowledge of the individual limb function was obtained.

A single pulse TMS of the motor cortex was performed with a circular coil of 90 mm diameter of MAGSTIM 200 (2 Tesla version, Magstim Co., Dyfed, UK) stimulator pulsed with a very brief (less than 200 microsecond) current and generating maximum magnetic field of 2 Tesla. The center of the coil was positioned over the vertex for cortical stimulation of the upper limbs, and slightly anterior to the vertex for stimulation of the lower limbs. Since the motor cortex is more sensitive to current flowing from posterior to anterior, a clockwise current flow (side B up) was used for right motor cortex activation, and a counter-clockwise flow (side A up) for the left cortex activation.[19] The filter setting used was 100 Hz low filter and 10 KHz high filter. The signals were recorded with a conventional EMG machine (Nicolet Biomedical Inc., Madison, USA) bilaterally from the abductor pollicis brevis (APB) in the upper limbs and from the tibialis anterior (TA) in the lower limbs by surface silver/silver chloride electrodes in a belly-tendon montage. The nerve conduction studies by electrical stimulation were also performed for median and deep peroneal nerves in all the subjects using the same EMG machine.

The subjects were seated in a chair and threshold intensity (TI) was recorded in a relaxed target muscle. TI was taken as the minimum stimulus intensity (measured as a percentage of maximum output intensity of the stimulator) needed to evoke a response >20 mV in three out of five trials.[20] If no response was recorded even at maximum coil output (100%), the subjects were asked to contract target muscle and if still no response was recorded, then TI was considered as 100%.[21] The subjects were then asked to maintain mild isometric contraction (10-20% of maximal effort) of the target muscles and stimuli were given at intensities at least 30% above TI and 6-10 motor evoked potentials (MEP) were recorded; those with shortest latency and largest amplitude were evaluated. The magnetic stimulation of the spinal roots was done by placing the rim of the same coil over the seventh cervical and fifth lumbar vertebrae. CMCT was measured by subtracting the latency resulting from spinal stimulation from that on cortical stimulation. The parameters evaluated were: TI; cortical-APB/TA latencies (CL) and spinal cord (cervical/LS spine)-APB/TA latencies; amplitude (AM) of MEP; CMCT and inter-side differences in CL and CMCT between the hemispheres.

All patients also underwent cerebrospinal fluid (CSF) analysis for oligoclonal bands (OCB) by polyacrylamide gel electrophoresis (PAGE), visual (VEP) and auditory (BAER) evoked potentials and MRI of brain and/or spinal cord. Follow-up clinical and electrophysiological evaluation was performed in all the patients at three months after the initial TMS study.

Normal ranges were established from a group of 30 age and sex-matched healthy controls. The upper limits of normality for CL and CMCT were taken as 2 SD above the mean and the lower limit of normality for the AM as 2 SD below the mean values of controls [Table - 1]. The latencies and CMCT were considered abnormal when the responses were either absent or the value of the parameter exceeded the upper limits of the normality. In case of MEP abnormality in one limb, we considered this finding as a sign of sub-clinical pyramidal tract involvement if there were no signs of corticospinal involvement in all other limbs.

Statistical analysis between the patient and control results was performed using t-test. The clinical and electrophysiological findings were correlated using Mann-Whitney U-Wilcoxon rank sum test for group data comparisons and Spearman Rank correlation test.


 ╗ Results Top


Thirty patients of MS, 17 females, 13 males (age range 12-50 years; mean 30.4▒10.8), and 30 healthy controls, 13 females and 17 males (age range 14-45 years; mean 29.7▒7.02), were evaluated. The grades of pyramidal and cerebellar dysfunction and the degree of abnormal motor signs in both the upper and lower limbs are summarized in [Table - 2]. At inclusion, five patients had normal pyramidal function; out of these, two patients had normal cerebellar function also. The interval from the first onset of symptoms to the first electrophysiological examination was 32.03▒44.6 months (range 5 days to 18 years).

TMS was well tolerated by all the subjects without any immediate or delayed untoward side effects. In total, 119 limbs were studied; MEPs could be elicited in all the four limbs in controls and 57/60 upper limbs and 36/59 lower limbs in the study group [Table - 1].

The mean TI, CMCT and CL were significantly prolonged in all the limbs ( P <0.001) and the mean AM on cortical stimulation was significantly reduced in the upper limbs ( P <0.001) in MS patients as compared to the controls. At least one parameter was found to be abnormal in 40% right upper limbs, 50% left upper limbs, 70% right lower limbs and 72.4% left lower limbs. Overall, at least one parameter was abnormal in 68/119 (57.1%) of the total limbs studied. Diagnostic yield of TMS was found to be 76.7% in the upper limbs and 93.3% in the lower limbs. Thus, 28/30 (86.7%) patients had one parameter abnormal in at least one of their limbs. Additional abnormal inter-side asymmetries in either CL and/or CMCT were found in 3(10%) patients. Hence, the diagnostic yield of TMS in our study was 96.7%. In comparison, the diagnostic yield of VEP was 74.7%, BAER 13.3% and CSF OCB 10%.

In the upper limbs, the mean CMCT correlated significantly with the degree of hypereflexia (r=0.34, P =0.01), Hoffmann score (r=0.34, P =0.01), limb ataxia (r=0.32, P =0.017), dysdiadokokinesia (r=0.33, P =0.012) and intention tremor (r=0.33, P =0.012). In the lower limbs, mean CMCT correlated significantly with the degree of hyperreflexia (r=0.49, P =0.002) and in the left lower limbs with pyramidal dysfunction (r=0.65, P =0.05). No correlation was found in EDSS and CMCT abnormalities in any of the limbs [Table - 3].

On follow-up, 17(56.7%) patients improved clinically, 11(36.7%) worsened clinically and 2(6.6%) remained clinically stable. Clinical improvement or worsening on follow-up was considered as change in EDSS by one or more points. For follow-up analysis, only the limbs that had abnormal CMCT at inclusion were studied. In total, 24 upper limbs and 12 lower limbs could be evaluated. In patients who improved clinically (n=12), CMCT showed a corresponding reduction in 14/15(93.3%) upper and 9/9(100%) lower limbs; mean CMCT improved significantly from 17.07 msec. to 14.53 msec. ( P <0.001) [paired t-test] in the upper limbs and from 34.7 msec. to 25.9 msec. ( P <0.001) in the lower limbs. On the other hand, in patients who remained clinically stable or worsened (n=13), CMCT showed a corresponding worsening in 7/9(77.8%) upper and 1/3(33.3%) lower limbs; mean CMCT worsened from 19.18 msec. to 24.98 msec. in the upper limbs ( P >0.05) and from 24.5 msec. to 27.13 msec. in the lower limbs ( P >0.05) [Figure - 1].


 ╗ Discussion Top


The results of the present study show that TMS parameters are significantly altered in clinically definite MS patients as compared to the controls. The diagnostic yield of TMS was higher than that of VEP, BAER and CSF OCB, akin to previous reports.[9],[13],[20],[22],[23],[24],[25],[26],[27],[28],[29] There are no Indian studies available on the role of TMS in MS patients. The diagnostic yield of CSF OCB in our patients was low similar to other Asian studies. The reported CSF OCB positivity in Asian studies varied between 27% and 45%.[23],[24],[25] Since we do not have the methodology to assess lesion volume and lesion load, we have not correlated MRI findings and TMS parameters.

The diagnostic yield of TMS increases whenever more than one limb is tested and abnormal asymmetries between the limbs are taken into consideration.[9],[13] In our study 96.7% of the patients had at least one abnormal parameter or abnormal inter-side asymmetries in the parameters. This incidence of abnormalities in our study was higher than that previously reported in MS.[8],[9],[13] This could be have resulted from the evaluation of both the upper and lower limbs, thus a larger segment of spinal cord. In our study examination of the upper limbs alone had resulted in a diagnostic yield of 76.7%, similar to the other studies that evaluated upper limbs only.[9],[22] We found a higher incidence of abnormal MEP in the lower limbs when compared to the upper limbs. Recording from the lower limbs allows the efferent volley to traverse a longer path through the cranio-spinal axis. We considered all the non-stimulable responses to be abnormal because MEP could easily be elicited in all the four limbs of the healthy controls. Silent lesions were detected in one patient (3.3%) who had no clinical evidence of pyramidal and cerebellar dysfunction. Similar findings were observed in the earlier studies.[9],[11],[12],[13]

The present study confirms the observation that CMCT measurements correlate positively with motor disability.[12],[13] The lack of correlation between CMCT abnormalities and EDSS is possibly because EDSS takes into account overall clinical disability, i.e., both pyramidal and non-pyramidal tract lesions. The effects of cerebellar dysfunction on TMS results are not well known. We found a significant positive relation between CMCT abnormalities in the upper limbs and limb ataxia, intention tremor, dysdiadokokinesia and overall cerebellar scale score. Previous observations point that cerebellar dysfunction might play a role in the CMCT abnormalities by TMS.[13],[14] It however, might be over-represented due to co-incidental pyramidal tract involvement.

In our patients, there was improvement in CMCT parameters corresponding with clinical improvement, although the number of patients evaluated was small. Mean CMCT of the total group studied, improved significantly in patients who had improved clinically, whereas the mean CMCT of the total group worsened in patients who worsened clinically or remained stable. Similar results have been reported previously after steroid therapy[12],[21],[26],[27] and physiotherapy.[28]

TI is a measure of the cortico-cortical excitability of pyramidal neurons. The increased TI and reduced AM may occur due to temporal dispersion of descending volleys or conduction blocks in the descending motor pathways. The CMCT prolongation in MS occurs secondary to delayed supra-threshold stimulation of smaller and slower conducting motor neurons and a compromise in the stimulus conduction in large diameter demyelinated or incompletely remyelinated corticospinal fibers, resulting in lack of temporal summation.[21],[22],[26],[29] The absence of MEP elicitation results from conduction failure secondary to demyelination across the zone of pathology.[26]

In conclusion, the present study suggests that TMS should be taken into account as a tool in monitoring motor disability in patients with MS, owing to the frequency of lesions in cortico-spinal pathways and the significant correlation observed between the abnormalities in CMCT and the degree of motor disability. In order to further define the potential role of TMS in the characterization of MS-related disability, especially in patients with primary or secondary progressive disease course, large prospective serial studies are required.



 
 ╗ References Top

1.Comi G, Leocani L, Medaglini S, Locatelli T, Martinelli V, Santuccio G, et al . Evoked potentials in diagnosis and monitoring of multiple sclerosis. Electroencephalogr Clin Neurophysiol 1999;49:S13-S18.  Back to cited text no. 1    
2.Leocani L, Comi G. Neurophysiological investigations in multiple sclerosis. Curr Opin Neurol 2000;13:255-61.  Back to cited text no. 2  [PUBMED]  
3.Fuhr P, Kappos L. Evoked potentials for evaluation of multiple sclerosis. Clin Neurophysiol 2001;112:2185-9.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Mayr N, Baumgartner C, Zeitlhofer J, Deecke L. The sensitivity of transcranial magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology 1991;41:566-9.  Back to cited text no. 4  [PUBMED]  
5.Rovnborg M, Liguori R, Christiansen P, Larsson H, Sψrensen PS. The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 1992;42:1296-301.  Back to cited text no. 5    
6.Michels R, Wessel K, Kl φhn S, K φmpf D. Long latency reflexes, somatosensory evoked potentials and trancranial magnetic stimulation: Relation of the three methods in multiple sclerosis. Electroencephalogr Clin Neurophysiol 1993;89:235-241.  Back to cited text no. 6    
7.Beer S, R φsler KM, Hess CW. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry 1995;59:152-9.  Back to cited text no. 7    
8.Barker AT, Freeston IL, Jalinous R, Jarratt JA. Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain. Lancet 1986;1:1325-6.  Back to cited text no. 8    
9.Hess CW, Mills KR, Murray NMF, Schriefer TN. Magnetic brain stimulation: Central motor conduction in multiple sclerosis. Ann Neurol 1987;22:744-52.  Back to cited text no. 9    
10.Kandler RH, Jarratt JA, Gumpert EJW, Davies-Jones GAB, Venables GS, Sagar HJ. The role of magnetic stimulation in the diagnosis of multiple sclerosis. J Neurol Sci 1991;106:25-30.  Back to cited text no. 10    
11.Ingram DA, Thompson AJ, Swash MJ. Central motor conduction in multiple sclerosis: Evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain. J Neurol Neurosurg Psychiatry 1988;51:487-94.  Back to cited text no. 11    
12.Kandler RH, Jarratt JA, Gumpert EJW, Davies-Jones GAB, Venables GS, Sagar HJ, et al . The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci 1991;106:31-4.  Back to cited text no. 12    
13.Cruz-Martinez A, Gonzalez-Orodea JI, Lopez PR, Arpa J. Disability in multiple sclerosis. The role of transcranial magnetic stimulation. Electromyogr Clin Neurophysiol 2000;40:441-7.  Back to cited text no. 13    
14.Cruz MA, Arpa J, Alonso M, Palomo F, Villoslada C. Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurol Scand 1995;92:218-24.  Back to cited text no. 14    
15.Cruz-Martinez A, Arpa J. Transcranial magnetic stimulation in patients with cerebellar stroke. Eur Neurol 1997;38:82-7.  Back to cited text no. 15  [PUBMED]  
16.Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Johnson KP, et al . New diagnostic criteria for Multiple Sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.  Back to cited text no. 16    
17.Kurtzke JF. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.  Back to cited text no. 17  [PUBMED]  
18.Klockgether T, Schroth G, Diener HC, Dichgangs J. Idiopathic cerebellar ataxia of late onset: Natural history and MRI morphology. J Neurol Neurosurg Psychiatry 1990;53:297-305.  Back to cited text no. 18    
19.Macdonell RAL, Shapiro BE, Chiappa KH, Helmers SL, Cros D, Day BJ, et al . Hemispheric threshold differences for motor evoked potentials produced by magnetic coil stimulation. Neurology 1991;41:1441-4.  Back to cited text no. 19    
20.Schmierer K, Irlbacher K, Grosse P, R φricht S, Meyer BU. Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation. Neurology 2002;59:1218-24.  Back to cited text no. 20    
21.Fierro B, Salemi G, Brighina F, Buffa D, Conte S, La Bua V, et al . A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 2002;105:152-7.  Back to cited text no. 21    
22.Caramia MD, Bernardi G, Zarola F, Rossini PM. Neurophysiological evaluation of the central impulse propagation in patients with sensorimotor disturbances. Electroencephal Clin Neurophysiol 1988;70:16-25.  Back to cited text no. 22    
23.Bansil S, Singhal BS, Ahuja GK, Ladiwala U, Behari M, Friede R, et al . Comparison between multiple sclerosis in Indian and United States: A case control study. Neurology 1996;46:385-7.  Back to cited text no. 23    
24.Syal P, Prabhakar S, Thussu A. Clinical profile of multiple sclerosis in North-West India. Neurol India 1999;47:12-7.  Back to cited text no. 24    
25.Chong HT, Li PCK, Ong B, Lee KH, Tsai CP, Singhal BS, et al . Severe spinal cord involvement is a universal feature of Asians with multiple sclerosis: A joint Asian study. Neurol J Southeast Asia 2002;7:35-40.  Back to cited text no. 25    
26.Salle JY, Hugon J, Tabaraud F, Boulestiex JM, Vallat JM, Dumas W, et al . Improvement in motor evoked potentials and clinical course post steroid therapy in multiple sclerosis. J Neurol Sci 1992;108:184-8.  Back to cited text no. 26    
27.Caramia MD, Cicinelli P, Paradiso C, Moriorenzi R, Zarola F, Barnardi G, et al . Excitability changes of muscular responses to magnetic stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol 1991;81:243-50.  Back to cited text no. 27    
28.Kandler RH, Childs J. Changes in central motor conduction with physiotherapy in multiple sclerosis: A case report. Clin Rehab 1990;4:57-62.  Back to cited text no. 28    
29.Andersson T, Sidιn ┼, Persson A. A comparison of motor evoked potentials in patients with multiple sclerosis and potentially related conditions. Electromyogr Clin Neurophysiol 1995;35:17-24.  Back to cited text no. 29    


Figures

[Figure - 1]

Tables

[Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis
Marion Simpson,Richard Macdonell
Multiple Sclerosis and Related Disorders. 2015; 4(5): 430
[Pubmed] | [DOI]
2 Optimization of the Transcranial Magnetic Stimulation Protocol by Defining a Reliable Estimate for Corticospinal Excitability
Koen Cuypers,Herbert Thijs,Raf L. J. Meesen,Hugo Theoret
PLoS ONE. 2014; 9(1): e86380
[Pubmed] | [DOI]
3 Usage of multimodal evoked potentials in diagnosis of central nervous system changes in multiple sclerosis [Multipl sklerozlu hastalarda santral sinir sistemi deg̀isikliklerinin tani{dotless
├ľzbek, B. and Balci, K. and ├çelik, Y.
Turk Noroloji Dergisi. 2011; 17(1): 38-44
[Pubmed]
4 Brain Excitability Changes in the Relapsing and Remitting Phases of Multiple Sclerosis: A Study with Transcranial Magnetic Stimulation
Allah Elshehaby, F.G. and Ebrahim, M.H. and Mohamed, M.A.E. and Mohamed, W.F. and Ahmed, A.E.
Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2010; 47(4): 535-540
[Pubmed]
5 Electrophysiological and clinical correlates of corpus callosum atrophy in patients with multiple sclerosis
N. Kale, J. Agaoglu, O. Tanik
Neurological Research. 2010; 32(8): 886
[VIEW] | [DOI]
6 Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis
N. Kale,J. Agaoglu,G. Onder,O. Tanik
Journal of Clinical Neuroscience. 2009; 16(11): 1439
[Pubmed] | [DOI]
7 Motor evoked potentials modification in different forms and stages of multiple sclerosis
Bolbocean, O. and Bohotin, V. and Popescu, C.D.
Romanian Journal of Neurology/ Revista Romana de Neurologie. 2009; 8(3): 119-123
[Pubmed]
8 Motor pathway abnormality in multiple sclerosis
Bolbocean, O. and Bohotin, V. and Popescu, C.D.
Romanian Journal of Neurology/ Revista Romana de Neurologie. 2009; 8(3): 115-118
[Pubmed]
9 Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis
Kale, N., Agaoglu, J., Onder, G., Tanik, O
Journal of Clinical Neuroscience. 2009; 16(11): 1-2
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow